SunRISe Study – Stroke Rehabilitation In Suriname


This study aims to determine the effect of a supervised home-based physical fitness program on the aerobic capacity, quality of gait and health related quality of life in people with chronic ischemic stroke. Secondly, feasibility of the program for implementing a long term lifestyle change will be investigated.

Full Title of Study: “The Effect of a Tele-supervised Home Based Rehabilitation Program on Physical Fitness, Quality of Gait, Upper Limb Disability and Quality of Life in People After Chronic Stroke in a Urban Setting in Suriname. Randomised Controlled Trial.”

Study Type

  • Study Type: Interventional
  • Study Design
    • Allocation: Randomized
    • Intervention Model: Parallel Assignment
    • Primary Purpose: Treatment
    • Masking: None (Open Label)
  • Study Primary Completion Date: April 2017


  • Behavioral: Home base stroke rehabilitation
    • The intervention consists of physiotherapy exercises targeting functional and physical capacity.

Arms, Groups and Cohorts

  • Experimental: Intervention group
    • Stroke patients from the intervention group will be, on top of usual care, offered a holistic home based and semi-supervised stroke rehabilitation program followed by a period of tele-supervision.
  • No Intervention: Control group
    • The participants in the control group will only receive usual care.

Clinical Trial Outcome Measures

Primary Measures

  • Change in peak oxygen uptake
    • Time Frame: 4 weeks, 8 weeks and 5 months after start of rehabilitation

Participating in This Clinical Trial

Inclusion Criteria

  • ability to give informed consent – ability to understand measurement procedures defined as MMSE >24 – last stroke >6 months ago – mild to moderate stroke deficit defined by Fugl Meyer test score of 27 to 90 for upper and lower extremities – FAC ≥3 – medical clearance to participate in a moderate exercise program – living at home and having a minimum of 5 stairs at home Exclusion Criteria:
  • serious cardiac condition – other serious end organ damage – other neurological deficits leading to disability – uncontrolled blood pressure (systolic pressure >140, diastolic pressure >90)
  • Gender Eligibility: All

    Minimum Age: N/A

    Maximum Age: N/A

    Are Healthy Volunteers Accepted: No

    Investigator Details

    • Lead Sponsor
      • KU Leuven
    • Collaborator
      • Anton De Kom University
    • Provider of Information About this Clinical Study
      • Principal Investigator: Roselien Buys, Dr. – KU Leuven

    Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

    At, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.